Literature DB >> 1006976

Investigations on allergic and serological reactions following inoculation of inactivated smallpox vaccines by cutaneous scarification.

A Giurcă, V L Topciu, D Voiculescu, E Moldovan, L Plavoşin.   

Abstract

A number of 154 young adults were given a smallpox vaccine inactivated by UV (103 subjects) or by 4degrees/00 formol (51 subjects). Inoculation induced an early cutaneous reaction in 75.4% of the revaccinated subjects. The incidence of positive HAI reactions in this group increased from 30.2% before vaccination to 63.8% after inoculation, while the geometric mean titer increased from 2.88 to 10.73. This would prove the early reactions to be allergic responses of organisms sensitized against smallpox vaccine, capable of stimulating antibody formation. No cutaneous reaction was recorded in the 7 persons vaccinated for the first time (without pre-existent cutaneous scars). These subjects developed neither cutaneous nor humoral response to the killed virus, as there was no previous sensitization to the respective antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1006976

Source DB:  PubMed          Journal:  Virologie        ISSN: 0253-181X            Impact factor:   0.474


  3 in total

1.  Response to cutaneous immunization with low-molecular-weight subunit keyhole limpet hemocyanin.

Authors:  Henry Milgrom; Karen Kesler; Margie Byron; Ron Harbeck; Robert Holliday; Donald Y M Leung
Journal:  Int Arch Allergy Immunol       Date:  2011-10-28       Impact factor: 2.749

2.  Poor Antigen Processing of Poxvirus Particles Limits CD4+ T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.

Authors:  Katherine S Forsyth; Brian DeHaven; Mark Mendonca; Sinu Paul; Alessandro Sette; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2019-01-30       Impact factor: 5.422

Review 3.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.